ES537909A0 - Procedimiento para la preparacion de anticuerpos contra digitalis - Google Patents
Procedimiento para la preparacion de anticuerpos contra digitalisInfo
- Publication number
- ES537909A0 ES537909A0 ES537909A ES537909A ES537909A0 ES 537909 A0 ES537909 A0 ES 537909A0 ES 537909 A ES537909 A ES 537909A ES 537909 A ES537909 A ES 537909A ES 537909 A0 ES537909 A0 ES 537909A0
- Authority
- ES
- Spain
- Prior art keywords
- digitalis
- antibodies
- immunologically
- active
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000208011 Digitalis Species 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000526 Papain Proteins 0.000 abstract 2
- 239000004365 Protease Substances 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 229940055729 papain Drugs 0.000 abstract 2
- 235000019834 papain Nutrition 0.000 abstract 2
- WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 abstract 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 abstract 1
- 102000006395 Globulins Human genes 0.000 abstract 1
- 108010044091 Globulins Proteins 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010070863 Toxicity to various agents Diseases 0.000 abstract 1
- 239000003463 adsorbent Substances 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 229940082657 digitalis glycosides Drugs 0.000 abstract 1
- 229960000648 digitoxin Drugs 0.000 abstract 1
- -1 digitoxin aldehyde Chemical class 0.000 abstract 1
- 229960005156 digoxin Drugs 0.000 abstract 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 abstract 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9453—Cardioregulators, e.g. antihypotensives, antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833342870 DE3342870A1 (de) | 1983-11-26 | 1983-11-26 | Digitalis-antikoerper, verfahren zu ihrer herstellung und ihre verwendung zur therapie von digitalis-intoxikationen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES537909A0 true ES537909A0 (es) | 1985-11-01 |
| ES8600770A1 ES8600770A1 (es) | 1985-11-01 |
Family
ID=6215371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES537909A Expired ES8600770A1 (es) | 1983-11-26 | 1984-11-23 | Procedimiento para la preparacion de anticuerpos contra digitalis |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4742159A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0143413B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPS60132922A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE64141T1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA1242393A (cg-RX-API-DMAC7.html) |
| DE (2) | DE3342870A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES8600770A1 (cg-RX-API-DMAC7.html) |
| SU (1) | SU1455999A3 (cg-RX-API-DMAC7.html) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4849352A (en) | 1984-10-09 | 1989-07-18 | Sullivan John B | Antibody purification process |
| US4841024A (en) * | 1986-09-15 | 1989-06-20 | Becton Dickinson And Company | Purification of antibodies |
| US4814433A (en) * | 1987-09-16 | 1989-03-21 | Miles Inc. | Method for obtaining a papain-free antibody fragment preparation |
| JPH0623761B2 (ja) * | 1988-12-09 | 1994-03-30 | 株式会社ピーシーシーテクノロジー | 配糖化した化合物を生産する細胞の検出方法 |
| US5328834A (en) * | 1989-09-08 | 1994-07-12 | Unisyn Technologies, Inc. | Method for preparing immunoglobulin fragments |
| FI955798L (fi) * | 1993-06-03 | 1996-02-01 | Therapeutic Antibodies Inc | Terapeuttiset vasta-ainefrangmentit |
| EP1293221A4 (en) * | 2000-05-25 | 2009-02-25 | Kaneka Corp | CARDIAC GLYCOSIDE ADSORBENT AND METHOD AND DEVICE FOR ADSORPTION AND REMOVAL OF CARDIAC GLYCOSIDE |
| FR2810667B1 (fr) * | 2000-06-23 | 2004-09-03 | Warner Lambert Co | Procede d'isolement et de purification d'une proteine, et proteine obtenue |
| US6802966B2 (en) | 2001-08-14 | 2004-10-12 | W. R. Grace & Co. Conn. | Solid compositions for selective adsorption from complex mixtures |
| US6987079B2 (en) * | 2001-08-14 | 2006-01-17 | W.R. Grace & Co.-Conn. | Supported catalyst systems |
| US7794716B2 (en) | 2002-07-25 | 2010-09-14 | Glenveigh Pharmaceuticals, Llc | Antibody composition and passive immunization against pregnancy-induced hypertension |
| EP2046385B1 (en) | 2006-07-03 | 2015-03-25 | Charles David Adair | Composition for modulating the expression of cell adhesion molecules |
| US20110287088A1 (en) | 2008-12-03 | 2011-11-24 | Research Development Foundation | Modulation of olfml-3 mediated angiogenesis |
| WO2013022599A1 (en) | 2011-08-05 | 2013-02-14 | Research Development Foundation | Improved methods and compositions for modulation of olfml3 mediated angiogenesis |
| CA2888345C (en) | 2012-10-24 | 2020-04-21 | Research Development Foundation | Jam-c antibodies and methods for treatment of cancer |
| CN114621346B (zh) | 2013-08-21 | 2025-06-10 | 德克萨斯州大学系统董事会 | 用于靶向连接蛋白半通道的组合物和方法 |
| AU2016365318B2 (en) | 2015-12-02 | 2024-04-18 | Board Of Regents, The University Of Texas System | Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof |
| WO2017096017A1 (en) | 2015-12-02 | 2017-06-08 | Stsciences, Inc. | Antibodies specific to glycosylated btla (b- and t- lymphocyte attenuator) |
| WO2017147561A1 (en) | 2016-02-26 | 2017-08-31 | The Board Of Regents Of The University Of Texas System | CONNEXIN (Cx) 43 HEMICHANNEL-BINDING ANTIBODIES AND USES THEREOF |
| KR102418372B1 (ko) | 2016-03-29 | 2022-07-08 | 주식회사 에스티큐브 | 글리코실화된 pd-l1에 특이적인 이중 기능 항체 및 이의 사용 방법 |
| EP3436480A4 (en) | 2016-03-30 | 2019-11-27 | Musc Foundation for Research Development | METHOD FOR THE TREATMENT AND DIAGNOSIS OF CANCER BY TARGETING GLYCOPROTEIN A REPETITION PREDOMINANT (GARP) AND FOR EFFECTIVE IMMUNOTHERAPY ALONE OR IN COMBINATION |
| WO2018017673A1 (en) | 2016-07-20 | 2018-01-25 | Stcube, Inc. | Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated pd-l1 |
| CN111148762A (zh) | 2017-05-31 | 2020-05-12 | 斯特库伯株式会社 | 免疫特异性结合至btn1a1的抗体和分子及其治疗性用途 |
| CN111051346A (zh) | 2017-05-31 | 2020-04-21 | 斯特库伯株式会社 | 使用免疫特异性结合btn1a1的抗体和分子治疗癌症的方法 |
| KR20200026209A (ko) | 2017-06-06 | 2020-03-10 | 주식회사 에스티큐브앤컴퍼니 | Btn1a1 또는 btn1a1-리간드에 결합하는 항체 및 분자를 사용하여 암을 치료하는 방법 |
| GB2581619A (en) | 2017-09-15 | 2020-08-26 | Univ California | Inhibition of aminoacylase 3 (AA3) in the treatment of cancer |
| CN111868039A (zh) | 2017-09-26 | 2020-10-30 | 加利福尼亚大学董事会 | 用于治疗癌症的组合物和方法 |
| EP3802616A4 (en) | 2018-06-04 | 2022-03-30 | University of Maryland, Baltimore | PROCEDURES FOR THE PREVENTION OF AN ACUTE KIDNEY LESION |
| CN114729045B (zh) | 2019-09-26 | 2025-09-09 | 斯特库比公司 | 对糖基化的ctla-4特异性的抗体及其使用方法 |
| EP4041768A1 (en) | 2019-10-09 | 2022-08-17 | StCube & Co. | Antibodies specific to glycosylated lag3 and methods of use thereof |
| WO2021167908A1 (en) | 2020-02-17 | 2021-08-26 | Board Of Regents, The University Of Texas System | Methods for expansion of tumor infiltrating lymphocytes and use thereof |
| CN113736744B (zh) * | 2021-10-14 | 2023-07-18 | 江南大学 | 洋地黄毒苷单克隆抗体杂交瘤细胞株及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3790475A (en) * | 1972-03-27 | 1974-02-05 | Corning Glass Works | Porous glass support material |
| US4039652A (en) * | 1973-10-11 | 1977-08-02 | Miles Laboratories, Inc. | Column method of immunoassay employing an immobilized binding partner |
| US4081246A (en) * | 1976-05-03 | 1978-03-28 | Beckman Instruments, Inc. | Solid phase column immunoassay procedure employing novel immunochemical composites |
| US4081245A (en) * | 1976-05-03 | 1978-03-28 | Beckman Instruments, Inc. | Immunoassay procedure employing novel immunochemical composites |
| US4232004A (en) * | 1977-09-21 | 1980-11-04 | American National Red Cross | Antibody-specific solid phase immunoadsorbent, preparation thereof, and antibody purification therewith |
| US4434234A (en) * | 1981-04-02 | 1984-02-28 | The Upjohn Company | Method and kit for silver staining substances supported in matrix |
-
1983
- 1983-11-26 DE DE19833342870 patent/DE3342870A1/de not_active Withdrawn
- 1983-12-19 US US06/563,217 patent/US4742159A/en not_active Expired - Lifetime
-
1984
- 1984-10-30 CA CA000466633A patent/CA1242393A/en not_active Expired
- 1984-11-17 AT AT84113943T patent/ATE64141T1/de not_active IP Right Cessation
- 1984-11-17 DE DE8484113943T patent/DE3484673D1/de not_active Expired - Lifetime
- 1984-11-17 EP EP84113943A patent/EP0143413B1/de not_active Expired - Lifetime
- 1984-11-23 SU SU843817568A patent/SU1455999A3/ru active
- 1984-11-23 ES ES537909A patent/ES8600770A1/es not_active Expired
- 1984-11-26 JP JP59248259A patent/JPS60132922A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60132922A (ja) | 1985-07-16 |
| EP0143413A3 (en) | 1988-07-20 |
| CA1242393A (en) | 1988-09-27 |
| JPH0324480B2 (cg-RX-API-DMAC7.html) | 1991-04-03 |
| DE3342870A1 (de) | 1985-06-05 |
| US4742159A (en) | 1988-05-03 |
| ES8600770A1 (es) | 1985-11-01 |
| ATE64141T1 (de) | 1991-06-15 |
| EP0143413A2 (de) | 1985-06-05 |
| DE3484673D1 (de) | 1991-07-11 |
| EP0143413B1 (de) | 1991-06-05 |
| SU1455999A3 (ru) | 1989-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES537909A0 (es) | Procedimiento para la preparacion de anticuerpos contra digitalis | |
| Kunkel et al. | Relation between certain myeloma proteins and normal gamma globulin | |
| Fischer‐Colbrie et al. | Isolation and immunological characterization of a glycoprotein from adrenal chromaffin granules | |
| DK96689D0 (da) | Fremgangsmaade til immunbestemmelse og diagnostisk middel til anvendelse ved fremgangsmaaden | |
| AU4926085A (en) | Immunoassays for protein analytes, particularly HB A1c, involving sample denaturation | |
| Imam et al. | Isolation and characterization of a major glycoprotein from milk-fat-globule membrane of human breast milk | |
| SE7909488L (sv) | Hemjernrikat aminosyrapreparat och forfarande for framstellning av hemjernrikade aminosyrapreparat fran hemproteiner | |
| Stanislawski-Birencwajg | Specific antigens of rat embryonic serum | |
| NZ237535A (en) | Carrier for binding anti-phospholipid antibodies, its use in immunoassays and kits and blood protein which enhances binding ability of antiphospholipid antibody | |
| Uriel et al. | Affinity chromatography of human, rat and mouse α-fetoprotein on estradiol-sepharose adsorbents | |
| AU564575B2 (en) | Polyvalent endotoxin specific antibodies | |
| Knight et al. | Papain cleavage of rabbit secretory immunoglobulin A. Differential sensitivity of f and g subclasses | |
| Bøg-Hansen et al. | A set of analytical electrophoresis experiments to predict the results of affinity chromatographic separations: fractionation of allergens from cow's hair and dander | |
| Pazur et al. | Anti-glycosyl antibodies. Two sets of isoantibodies with specificity for different carbohydrate moieties of the same glycosyl antigen. | |
| Lee et al. | Removal of unbound sodium dodecyl sulfate (SDS) from proteins in solution by electrophoresis through Triton X-100-agarose | |
| Kawakita | Immunochemical studies on the brain specific protein | |
| Svehag et al. | Ultrastructure of papain and pepsin digestion fragments of human IgM globulins | |
| Karamova et al. | Conformational variants of human alpha-fetoprotein | |
| Henson et al. | Isolation of serum fractions capable of producing Aleutian disease in mink | |
| Palmer | Affinity chromatography: Interactions between sepharose-linked and soluble γ-globulin | |
| MacGregor et al. | Isolation and characterisation of a surface membrane glycoprotein from adult Schistosoma mansoni | |
| RU2094078C1 (ru) | Хроматографический способ выделения альфа-фетопротеина | |
| Goudswaard et al. | Isolation of equine IgG (T) by hydrophobic interaction chromatography | |
| Davis et al. | Diazotized m-aminobenzyloxymethylcellulose as the insoluble matrix for an immunoadsorbent used in the purification of antigens and antibodies | |
| DE3568639D1 (en) | Method for the determination of a substance capable of immunological binding |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 20050528 |